Sexual and hormonal health
Female sexual concerns
Low desire, arousal difficulty, painful sex and orgasm concerns are separate problems. Menopause-related dryness requires a different approach from distressing low desire.
Potential benefits explored
Improved desire, arousal and sexual satisfaction.
Bremelanotide is relevant to a particular low-desire population; kisspeptin offers early human response research. Pain, lubrication and desire are separate concerns.
Practical interpretation
Match care to desire, arousal, pain or orgasm; review medicines, relationship context and menopausal symptoms.
Meaningful outcomes: The specific symptom, associated distress and satisfaction.
Compare the compounds studied for Female sexual concerns
Members see the full evidence picture for this condition: every compound studied, graded per condition from strong human evidence through to preclinical-only and negative findings, with human and animal results, risks, combination evidence and cited sources — plus how each compound maps to the research materials we list, with live pricing and stock.
Research reference for laboratory materials only. Not medical advice and not a recommendation for human use. Research cut-off: 30 September 2026.